Back
Biodexa Pharmaceuticals PLC 10K Form
Sell
23
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
$1.45
Seasonality Move:
-21.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BDRX News And Ratings
See the #1 stock for the next 7 days that we like better than BDRX
BDRX Financial Statistics
Sales & Book Value
| Annual Sales: | $474.1K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $30.44 |
| Price / Book: | 0.09 |
Profitability
| EPS (TTM): | -74.59720 |
|---|---|
| Net Income (TTM): | $-8.5M |
| Gross Margin: | $-6.9M |
| Return on Equity: | -160.77% |
| Return on Assets: | -87.8% |
Biodexa Pharmaceuticals PLC Earnings Forecast
Key Biodexa Pharmaceuticals PLC Financial Ratios
-
The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
-
Per Share Earnings over the last 12 years have been positive in 7 years.
Biodexa Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BDRX |
| Website: | biodexapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.26 |
| Quick Ratio: | 1.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BDRX Technical Analysis vs Fundamental Analysis
Sell
23
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy or a Sell?
-
Biodexa Pharmaceuticals PLC stock is rated a SellThe current Biodexa Pharmaceuticals PLC [BDRX] share price is $1.46. The Score for BDRX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.